Tacrosoft 0.03% Gel

Introduction

Tacrosoft is a prescription medication that contains the active ingredient Tacrolimus. It is available in the form of a gel for topical application.

Uses

Tacrosoft is primarily prescribed for the treatment of atopic dermatitis, a chronic inflammatory skin condition. It is indicated for use in adults and children aged 2 years and older.

Dosage and Administration

The dosage of Tacrosoft may vary depending on the severity of the condition and the individual’s response to treatment. Follow the instructions provided by your healthcare provider. Generally, a thin layer of the gel should be applied to the affected areas of the skin twice daily. Gently rub the gel into the skin until it is absorbed. Wash your hands after applying the gel, unless the hands are the affected area.

Mechanism of Action

Tacrolimus, the active ingredient in Tacrosoft, belongs to a class of medications known as calcineurin inhibitors. It works by suppressing the immune system in the skin, thereby reducing inflammation and alleviating the symptoms of atopic dermatitis. Tacrolimus specifically targets immune cells in the skin, helping to control the inflammatory response.

Side Effects

Common side effects may include burning, stinging, itching, or redness at the site of application. These side effects are usually mild and temporary. If any of these side effects persist or worsen, it is advisable to consult your healthcare provider.

In rare cases, serious side effects such as skin infections, skin thinning, or allergic reactions may occur. If you experience any signs of a severe allergic reaction, such as rash, itching, swelling, dizziness, or difficulty breathing, seek immediate medical attention.

Drug Interactions

inform your healthcare provider about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. Certain medications may interact with Tacrosoft and affect its effectiveness or increase the risk of side effects. Be sure to discuss potential drug interactions with your healthcare provider.

Precautions

Before using Tacrosoft, inform your healthcare provider if you have any known allergies, especially to Tacrolimus or any other ingredients present in the gel. Disclose your medical history, including any skin infections or other skin conditions.

Tacrosoft should not be used on infected or oozing skin. It is also not recommended for use in individuals with a weakened immune system. Avoid prolonged exposure to sunlight or artificial UV light while using this medication, as it may increase the risk of sunburn.

Storage

Store Tacrosoft at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets. Do not freeze the gel. Check the expiration date and do not use the gel if it has expired.

Patient Tips

• Follow the instructions provided by your healthcare provider regarding the application of Tacrosoft.
• Avoid using excessive amounts of the gel, as it may increase the risk of side effects.
• If you forget to apply the gel, apply it as soon as you remember. If it is close to the time for your next scheduled application, skip the missed dose and resume your regular dosing schedule.
• It may take several weeks of regular use for the full benefits of Tacrosoft to be seen. Be patient and continue using the gel as directed.
• If you have any questions or concerns about your treatment with Tacrosoft, consult your healthcare provider for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Vitiligo – Treatment (NHS UK) [Accessed 26 Jun. 2024] (online) Available at:
• Adoport 0.5 mg Hard Capsules (Health Professionals SmPC) Available at:
• Tacrolimus oral and injection (Drugs.com) [Accessed 3 Jun. 2024] (online) Available at:
• tacrolimus (RX) [Accessed 28 Jun. 2024] (online) Available at:
• Tacrolimus Injection (MedlinePlus) [Accessed 29 Jun. 2024] (online) Available at:
• Schutte-Nutgen K, Tholking G, Suwelack B, Reuter S. Tacrolimus – Pharmacokinetic Considerations for Clinicians. Curr Drug Metab. 2018;19(4):342-350. doi: 10.2174/1389200219666180101104159. [Accessed 6 Jun. 2024] Available at: